Clarivate Announces 15th Annual Pharmavision India Conference Agenda
Clarivate Plc (NYSE:CLVT) has announced the full agenda for the 15th annual Clarivate Pharmavision India conference, scheduled for September 25-26, 2024, in Ahmedabad and Hyderabad. The event focuses on improving patient outcomes and building resilience in the healthcare ecosystem. Key topics include AI in healthcare, cell and gene therapy, and market access.
The conference aims to address challenges such as healthcare affordability and access in India. Industry leaders will discuss strategies for patient-centric innovation, R&D, generics, biosimilars, and healthcare manufacturing. Notable sessions will cover topics like balancing generics and innovation, AI's role in healthcare, and addressing barriers to cell and gene therapy integration in India.
Clarivate Plc (NYSE:CLVT) ha annunciato l'agenda dettagliata per la 15ª conferenza annuale Clarivate Pharmavision India, prevista per il 25-26 settembre 2024, ad Ahmedabad e Hyderabad. L'evento si concentra su migliorare i risultati per i pazienti e costruire resilienza nell'ecosistema sanitario. I temi chiave includono intelligenza artificiale nella sanità, terapia cellulare e genica, e accesso al mercato.
La conferenza mira ad affrontare sfide come l'accessibilità e l'affordabilità sanitaria in India. I leader del settore discuteranno strategie per innovazione centrata sul paziente, R&S, generici, biosimilari, e produzione sanitaria. Sessioni notevoli tratteranno temi come il bilanciamento tra generici e innovazione, il ruolo dell'IA nella sanità, e l'affrontare le barriere all'integrazione della terapia cellulare e genica in India.
Clarivate Plc (NYSE:CLVT) ha anunciado la agenda completa para la 15ª conferencia anual Clarivate Pharmavision India, programada para el 25 y 26 de septiembre de 2024, en Ahmedabad y Hyderabad. El evento se centra en mejorar los resultados para los pacientes y construir resiliencia en el ecosistema de atención médica. Los temas clave incluyen IA en la atención médica, terapia celular y génica, y acceso al mercado.
La conferencia tiene como objetivo abordar desafíos como la asequibilidad y el acceso a la atención médica en India. Líderes de la industria discutirán estrategias para la innovación centrada en el paciente, I+D, genéricos, biosimilares y manufactura de atención médica. Las sesiones notables cubrirán temas como el equilibrio entre genéricos e innovación, el papel de la IA en la atención médica y la superación de barreras para la integración de la terapia celular y génica en India.
Clarivate Plc (NYSE:CLVT)는 2024년 9월 25일부터 26일까지 아마다바드와 하이데라바드에서 열리는 15회 Clarivate Pharmavision India 컨퍼런스의 전체 일정을 발표했습니다. 이 행사는 환자 결과 개선 및 의료 생태계의 회복력 구축에 중점을 두고 있습니다. 주요 주제로는 의료 분야의 인공지능, 세포 및 유전자 치료, 시장 접근성이 포함됩니다.
컨퍼런스는 인도의 의료 비용과 접근성과 같은 문제를 해결하는 것을 목표로 합니다. 업계 리더들은 환자 중심의 혁신, R&D, 제너릭, 바이오시밀러, 의료 제조에 대한 전략을 논의할 것입니다. 주목할 만한 세션에서는 제너릭과 혁신의 균형, 의료 분야에서의 AI 역할, 인도에서의 세포 및 유전자 치료 통합 장벽을 해결하는 방법을 다룰 것입니다.
Clarivate Plc (NYSE:CLVT) a annoncé l'agenda complet de la 15e conférence annuelle Clarivate Pharmavision India, prévue les 25 et 26 septembre 2024 à Ahmedabad et Hyderabad. L'événement se concentre sur l'amélioration des résultats pour les patients et la construction de résilience au sein de l'écosystème de santé. Les principaux sujets incluent l'IA dans le secteur de la santé, la thérapie génique et cellulaire, et l'accès au marché.
La conférence vise à aborder des défis tels que l'accessibilité et l'affordabilité des soins de santé en Inde. Des leaders de l'industrie discuteront des stratégies pour l'innovation centrée sur le patient, R&D, les génériques, les biosimilaires et la fabrication de soins de santé. Des sessions notables traiteront des thèmes tels que l'équilibre entre les génériques et l'innovation, le rôle de l'IA dans le secteur de la santé et la façon de surmonter les obstacles à l'intégration des thérapies géniques et cellulaires en Inde.
Clarivate Plc (NYSE:CLVT) hat die vollständige Agenda für die 15. jährliche Clarivate Pharmavision Indien-Konferenz bekannt gegeben, die für den 25. und 26. September 2024 in Ahmedabad und Hyderabad angesetzt ist. Die Veranstaltung konzentriert sich auf die Verbesserung der Patientenergebnisse und den Aufbau von Resilienz im Gesundheitsökosystem. Zu den wichtigsten Themen gehören KI im Gesundheitswesen, zelluläre und gentherapeutische Verfahren und Marktzugang.
Die Konferenz zielt darauf ab, Herausforderungen wie die Erschwinglichkeit und den Zugang zur Gesundheitsversorgung in Indien anzugehen. Branchenführer werden Strategien für patientenorientierte Innovation, F&E, Generika, Biosimilars und Gesundheitsproduktion diskutieren. Bemerkenswerte Sitzungen werden Themen wie das Gleichgewicht zwischen Generika und Innovation, die Rolle von KI im Gesundheitswesen und die Überwindung von Barrieren für die Integration von zellulären und gentherapeutischen Verfahren in Indien abdecken.
- Clarivate is hosting its 15th annual Pharmavision India conference, demonstrating long-term industry engagement
- The conference addresses critical issues in healthcare, potentially leading to industry advancements
- Participation of industry leaders may enhance Clarivate's reputation and network in the life sciences sector
- None.
Industry leaders to discuss AI in healthcare, cell and gene therapy, market access and more at premier life sciences event
In a country with billions of people, addressing challenges such as healthcare affordability and access is crucial. Organizations must adopt effective, patient-centric approaches across diverse functions to ensure return on investment and a competitive advantage. As the healthcare landscape evolves, balancing these priorities is essential for sustainable growth and better patient outcomes. Pharmavision India 2024 will provide attendees with the opportunity to tackle the industry's most urgent challenges in life sciences and healthcare.
Ramandeep Singh, Vice President, Life Sciences and Healthcare,
Henry Levy, President, Life Sciences and Healthcare, Clarivate, added: "At Clarivate, our mission is to foster collaboration across life sciences and healthcare industries, driving strategies that enhance patient outcomes and sustainable growth. We are proud to bring together industry leaders to tackle the vital challenge of integrating patient-centric innovation in today's evolving market through impactful forums such as Clarivate Pharmavision India."
This year's agenda features insights and perspectives from industry leaders and analysts, with sessions focused on innovative R&D, generics, biosimilars and healthcare manufacturing. Noteworthy sessions include:
- Indian Pharma: Generics versus innovation - finding the balance for success, by Dr. Keyur Parekh, President, Corporate Strategy, Zydus Lifesciences Limited
- The role of AI and big data in healthcare: Transformative impacts and future prospects, by Mr. Anirban Roy Chowdhury, Senior General Manager, Amneal Pharmaceuticals
- Cell and gene therapy: Addressing key barriers for successful integration into clinical practice in the Indian context, by Dr. Tulip Nuval, Head of Business Excellence, Intas Pharmaceuticals Limited
- Cell and gene therapy: Addressing key barriers for successful integration into clinical practice in the Indian context, by Mr. Rebu Ninan, Head of Commercial & Market Access, Immuneel Therapeutics Private Limited
- Patients and the LMIC story: How Indian companies drive affordability in the global scenario, by Dr. Rahul Kapur, Head - Medical Affairs (EM) and COE, Biocon Biologics Limited
- Creating value for patients and stakeholders, by Mr. Deepak Sapra, Chief Executive Officer, API and Services, Dr. Reddy's Laboratories
Pharmavision India takes place on Wednesday, September 25, 2024, at the Hyatt Ahmedabad, and Thursday, September 26, 2024, at the Taj Deccan,
Connect with Clarivate Life Sciences and Healthcare. Join the conversation and mention Clarivate and Pharmavision on X and LinkedIn. #Pharmavision #PatientCare #Biopharma #ThinkForward
About Clarivate
Clarivate™ is a leading global provider of transformative intelligence. We offer enriched data, insights & analytics, workflow solutions and expert services in the areas of Academia & Government, Intellectual Property and Life Sciences & Healthcare. For more information, please visit www.clarivate.com
Media Contact:
Catherine Daniel
Director External Communications, Life Sciences & Healthcare
newsroom@clarivate.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/clarivate-announces-15th-annual-pharmavision-india-conference-agenda-302250677.html
SOURCE Clarivate Plc
FAQ
When and where is the Clarivate Pharmavision India 2024 conference taking place?
What are the main topics to be discussed at the Clarivate (CLVT) Pharmavision India 2024 conference?
Who are some of the key speakers at the Clarivate (CLVT) Pharmavision India 2024 event?
What is the significance of the Clarivate (CLVT) Pharmavision India conference for the pharmaceutical industry?
